Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Fumoleau

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Cancer Chemotherapy and Pharmacology|November 25, 2003
Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancerR Deporte-Fety, N Simon, P Fumoleau, et al.
Bulletin Du Cancer|January 1, 1983
[Use of radio-labelled monoclonal antibodies for the scintigraphic detection of human colorectal cancers]J F Chatal, M Bourdoiseau, P Fumoleau, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|January 1, 1987
[Adjuvant treatment of osteosarcomas. Experience of the Group for the Study of Bone Tumors]C Jasmin, A Trifaud, N Delepine, et al.
Revue De Pneumologie Clinique|July 6, 2000
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]P Rebattu, B Coudert, M Schneider, et al.
Investigational New Drugs|September 22, 2012
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunctionJ P Delord, A Ravaud, J Bennouna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursJ Bennouna, P Fumoleau, J-P Armand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1991
Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patientsJ P Vuillez, P Peltier, J C Mayer, et al.
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of cystemustine in metastatic colorectal carcinoma. A trial of the EORTC Clinical Screening GroupP Kerbrat, A Adenis, P Rebattu, et al.
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Cancer Chemotherapy and Pharmacology|November 25, 2003
Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancerR Deporte-Fety, N Simon, P Fumoleau, et al.
Bulletin Du Cancer|January 1, 1983
[Use of radio-labelled monoclonal antibodies for the scintigraphic detection of human colorectal cancers]J F Chatal, M Bourdoiseau, P Fumoleau, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
Revue De Chirurgie Orthopedique Et Reparatrice De L'Appareil Moteur|January 1, 1987
[Adjuvant treatment of osteosarcomas. Experience of the Group for the Study of Bone Tumors]C Jasmin, A Trifaud, N Delepine, et al.
Revue De Pneumologie Clinique|July 6, 2000
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]P Rebattu, B Coudert, M Schneider, et al.
Investigational New Drugs|September 22, 2012
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunctionJ P Delord, A Ravaud, J Bennouna, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Phase I and pharmacokinetic study of the new vinca alkaloid vinflunine administered as a 10-min infusion every 3 weeks in patients with advanced solid tumoursJ Bennouna, P Fumoleau, J-P Armand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1991
Reproducibility of image interpretation in immunoscintigraphy performed with indium-111- and iodine-131-labeled OC125 F(ab')2 antibody injected into the same patientsJ P Vuillez, P Peltier, J C Mayer, et al.
Cancer Investigation|March 20, 2003
Cancer drug development in Europe: a selection of new agents under development at the European Drug Development NetworkD Lacombe, A Butler-Smith, P Therasse, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of cystemustine in metastatic colorectal carcinoma. A trial of the EORTC Clinical Screening GroupP Kerbrat, A Adenis, P Rebattu, et al.
Pageof 16